Читать книгу Modern Techniques in Cytopathology - Группа авторов - Страница 14

In September 1996, the National Cancer Institute (NCI) sponsored a consensus conference to define a uniform approach for reporting breast FNA biopsy cytology. Twenty years later, the executive of the International Academy of Cytology (IAC) named a Breast Group including cytopathologists, surgical pathologists, radiologists, surgeons, and oncologists to draft a standardized reporting system for breast FNA that could be employed widely in both developed and underdeveloped countries. The structured report includes management recommendations to enhance the clinicians’ use of breast FNAB and use of cells blocks, immunohistochemistry, in-situ hybridization, and other prognostic and diagnostic markers [7].

In 2007, the NCI sponsored the “Thyroid Fine-Needle Aspiration State of the Science Conference,” and in 2010 “The Bethesda System for Reporting Thyroid Cytopathology” (TBSRTC) monograph was published. Since then, there have been significant developments in molecular studies for thyroid lesions as well as changes in clinical management as reflected in the 2015 American Thyroid Association (ATA) guidelines and the introduction of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) [8, 9]. These revised reporting systems are important for the promotion of cytopathologist USFNA. They reflect the importance of integration of clinical, imaging, and cytologic findings, and integration of ancillary studies which enhance the role of the clinical cytopathologist in the future practice of medicine.